Clik here to view.
Clinton, aiming to curb inversion deals, looks to stop ‘earnings stripping’
(Reuters) — U.S. Democratic presidential candidate Hillary Clinton today plans to continue her push to crack down on companies that shift profits overseas, at a campaign stop in Iowa where she’s due to...
View ArticleClik here to view.
BionX inks EU distribution deal with Ottobock
BionX, previously known as BiOM, said today it inked a collaborative deal with Otto Bock Healthcare to exclusively distribute the BiOM prosthetic ankle in Germany, Austria, Switzerland and the...
View ArticleClik here to view.
FDA labels eVent Medical ventilator recall as Class 1
The FDA released a recall notice yesterday for eVent Medical’s LS, 5i and 7i Inspiration ventilators over an issue with faulty switches on the power board that can fail and cause a system shut down...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for December 9, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
OrthoSensor pulls in $3.9m
OrthoSensor today reported it raised $3.9 million in a new round of financing looking to bring in another $8.1 million before closing, according to an SEC filing. Dania Beach, Fla.-based Orthosensor...
View ArticleClik here to view.
Philips partners with Truven Health to integrate Micromedex into Tasy platform
Royal Philips (NYSE:PHG) said today it partnered with Truven Health Analytics to integrate Truven’s Micromedex Solutions into Philips’ Tasy health management platform. Truven’s Micromedex is an...
View ArticleClik here to view.
EndoStim officially spikes $35m IPO
EndoStim today officially spiked an initial public offering it hoped would raise $35 million for its neurostimulation device for gastroesophageal reflux disease. EndoStim, which had planned to put $10...
View ArticleClik here to view.
Neosensory brings in $4.2m for hearing-to-vibration ‘sensory-addition’ vest
Stealth developer Neosensory raised $4.2 million in a new round of equity financing, according to an SEC filing, to fund a ‘sensing’ vest that could help the deaf learn to hear through vibrations. The...
View ArticleClik here to view.
Anika assigned to FDA’s drug eval arm for Cingal approval
Anika Therapeutics today said the FDA’s Office of Combination Products assigned the company’s Cingal drug-combo to its Center for Drug Evaluation and Research arm to pursue premarket regulatory...
View ArticleClik here to view.
Boston Scientific recalls Chariot sheaths; FDA labels it Class I
Boston Scientific (NYSE:BSX) said today it initiated a voluntary recall of its Chariot Guiding Sheaths designed to be used during peripheral vascular procedures due to the risk of shaft separation. The...
View ArticleClik here to view.
Looking to a backup gene to fight spinal muscular atrophy
Spinal muscular atrophy (SMA), a condition affecting one in every 6,000 to 10,000 children, is caused by a defect in a gene called SMN1 — which stands for “survival of motor neuron.” The defect leaves...
View ArticleClik here to view.
Analogic faces $15m bribery settlement, misses on Q1 earnings but shares stay...
Analogic (NSDQ:ALOG) said yesterday it may face a $15 million settlement with the U.S. gov’t over a foreign corruption investigation, and released 1st quarter 2016 earnings that missed on forecasted...
View ArticleClik here to view.
NeuroSigma touts preliminary eTNS traumatic brain injury trial results
NeuroSigma Systems today released preliminary data from a trial of its Monarch trigeminal nerve stimulation system designed to treat combat veterans with traumatic brain injuries, citing improvements...
View ArticleClik here to view.
Edwards looks bullish on TAVR market as it releases 2016 guidance
Edwards Lifesciences (NYSE:EW) yesterday released financial strategies and guidance for the fiscal year 2016, raising expectations for the transcatheter heart valve market as a whole, as well as its...
View ArticleClik here to view.
J&J, Google’s Verily partner to form robotic-platform developer Verb Surgical
Johnson & Johnson (NYSE:JNJ) said today it is partnering with newly-titled Verily Life Sciences, formerly Google Life Sciences, to form Verb Surgical, which aims to develop a robotic surgical...
View ArticleClik here to view.
CareFusion wins dual FDA 510(k) for vertebral balloons
Becton Dickinson & Co. (NYSE:BDX) subsidiary CareFusion said today it won FDA 510(k) clearances for 2 sizes of vertebral balloon systems designed for spinal augmentations. The company received...
View ArticleClik here to view.
Biotronik launches CLS-equipped pacer trial for treating syncope
Biotronik said today it enrolled the 1st patients in its BioSync CLS trial looking to examine whether its closed loop stimulation-equipped pacemakers can prevent syncope. Recurrent syncope, or...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for December 10, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
NuVasive reiterates 2015 guidance, issues prelim 2016, announces new facilities.
NuVasive Inc. (NSDQ:NUVA) today released a report on its financial outlook, including reiterating its 2015 guidance in issuing preliminary 2016 figures, as well as announcing the opening of a new...
View ArticleClik here to view.
Pulmonx touts Chartis, Zephyr combo-treatment study
Pulmonx said today data from the Stelvio trial of its Chartis system and Zephyr endobronchial valve demonstrated statistically and clinically significant outcomes in lung function, exercise capacity...
View Article